Difference between revisions of "Glypican 3"
Jump to navigation
Jump to search
(create) |
|||
| Line 3: | Line 3: | ||
==Positive== | ==Positive== | ||
*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal | last1 = Aydin | first1 = O. | last2 = Yildiz | first2 = L. | last3 = Baris | first3 = S. | last4 = Dundar | first4 = C. | last5 = Karagoz | first5 = F. | title = Expression of Glypican 3 in low and high grade urothelial carcinomas. | journal = Diagn Pathol | volume = 10 | issue = | pages = 34 | month = | year = 2015 | doi = 10.1186/s13000-015-0266-4 | PMID = 25896897 }}</ref> | *[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal | last1 = Aydin | first1 = O. | last2 = Yildiz | first2 = L. | last3 = Baris | first3 = S. | last4 = Dundar | first4 = C. | last5 = Karagoz | first5 = F. | title = Expression of Glypican 3 in low and high grade urothelial carcinomas. | journal = Diagn Pathol | volume = 10 | issue = | pages = 34 | month = | year = 2015 | doi = 10.1186/s13000-015-0266-4 | PMID = 25896897 }}</ref> | ||
*[[Malignant melanoma]].<ref name=pmid25896897/> | |||
*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/> | |||
*[[Yolk sac tumour]]. | |||
===Images=== | |||
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/> | |||
==See also== | ==See also== | ||
Revision as of 00:51, 30 September 2015
Glypican 3 is a common immunostain used in gastrointestinal pathology and genituorinary pathology.
Positive
- Hepatocellular carcinoma.[1]
- Malignant melanoma.[1]
- Squamous cell carcinoma of the lung.[1]
- Yolk sac tumour.